UMIN-CTR Clinical Trial

Basic information
Public title	A clinical study to evaluate the safety of plant-extracts containing foods. (SME-2021-04-FOSHUS)
Acronym	A clinical study to evaluate the safety of plant-extracts containing foods.
Scientific Title	A clinical study to evaluate the safety of plant-extracts containing foods. (SME-2021-04-FOSHUS)
Scientific Title:Acronym	A clinical study to evaluate the safety of plant-extracts containing foods.
Region	Japan

Condition
Condition	Not applicable
Classification by specialty	Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	To evaluate the safety of plant-extracts foods.
Basic objectives2	Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	Adverse reaction
Key secondary outcomes	Adverse event Laboratory test value, Physical examination result

Base
Study type	Interventional

Study design
Basic design	Parallel
Randomization	Randomized
Randomization unit	Individual
Blinding	Double blind -all involved are blinded
Control	Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	2
Purpose of intervention	Prevention
Type of intervention	Food
Interventions/Control_1	Daily intake of test food for four weeks
Interventions/Control_2	Daily intake of control food for four weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	65 years-old >
Gender	Male and Female
Key inclusion criteria	(1) Those who are -> 20 years old at the time of IC acquisition and <65 years old at the end of food intake (2) Those who have submitted written informed consent after fully understanding the purpose and content of this study
Key exclusion criteria	(1) Those with systolic blood pressure less than 90 mmHg at the start of ingestion (2) Women who are/might be pregnant or lactating during the study (3) Those who have taken >=200 mL whole blood or blood donation within 4 weeks before the start of the intake (4) Men who have taken =>400 mL whole blood within 12 weeks before the start of intake (5) Women who have taken =>400 mL whole blood within 16 weeks before the start of intake (6) Men who have taken =>1,200 mL whole blood total (including the sampling of this study) within 12 months before the start of intake (7) Women who have taken =>800 mL whole blood total (including the sampling of this study) within 12 months before the start of intake (8) Those who are participating in other clinical study or planning to participate or participated within the past 4 weeks (9) Those who meet any of the following: (a) suffering from heart, liver, or kidney disease (including complications of other diseases) (b) having a history of cardiovascular disease (c) diabetes (d) allergic or highly sensitive to the test food (10) Those who are receiving any treatment at the time of screening (11) Those who regularly use pharmaceuticals (including quasi-drugs), foods for specified health use, foods with functional claims or health foods (12) Those who smoke an average of 21 or more cigarettes in a day (13) Those who drink an average of more than 60 g of pure alcohol in a day (14) Those who have an extremely irregular eating habit (15) Shift workers or midnight shift workers (16) Others who are judged inappropriate for participant by the investigators
Target sample size	48

Research contact person
Name of lead principal investigator	1st name Takao Middle name Last name Tanaka
Organization	SUNTORY MONOZUKURI EXPERT LIMITED
Division name	R&D Support Department HE Center
Zip code	135-8631
Address	2-3-3 Daiba, Minato-ku, Tokyo, Japan
TEL	03-5579-1277
Email	Takao_Tanaka@suntory.co.jp

Public contact
Name of contact person	1st name Noriko Middle name Last name Sekiguchi
Organization	SUNTORY MONOZUKURI EXPERT LIMITED
Division name	R&D Support Department HE Center
Zip code	135-8631
Address	2-3-3 Daiba, Minato-ku, Tokyo, Japan
TEL	03-5579-1277
Homepage URL
Email	N_Sekiguchi@suntory.co.jp

Sponsor
Institute	SUNTORY MONOZUKURI EXPERT LIMITED
Institute
Department

Funding Source
Organization	SUNTORY BEVARAGE & FOOD LIMITED
Organization
Division
Category of Funding Organization	Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	Miura Clinic, Medical Corporation Kanonkai IRB
Address	Higashitenma building 9F, 1-7-17, Higashitenma, Kita-ku, Osaka
Tel	06-6135-5200
Email	info@miura-cl.jp

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions	医療法人花音会みうらクリニック

Other administrative information
Date of disclosure of the study information	2021 Year 10 Month 06 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Completed
Date of protocol fixation	2021 Year 09 Month 30 Day
Date of IRB	2021 Year 09 Month 30 Day
Anticipated trial start date	2021 Year 10 Month 06 Day
Last follow-up date	2021 Year 12 Month 16 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date	2021 Year 10 Month 05 Day
Last modified on	2022 Year 10 Month 05 Day

Link to view the page
URL(English)	https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000052135